87 related articles for article (PubMed ID: 17134571)
1. [Expression of epithelial-cadherin, CD44v6 and connexin43 in hepatocellular carcinoma].
Zhang BY; Dai XW; Chen QY; Fang L; Qian B; Sun GY; Cui HH
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):616-9. PubMed ID: 17134571
[TBL] [Abstract][Full Text] [Related]
2. [A study of the relationship between the expression of connexin43, E-cadherin and biological behaviors of human laryngeal cancer].
Sun WH; Liu HM; Li YJ; Ji XR; Liang DP
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):293-7. PubMed ID: 15338868
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
[TBL] [Abstract][Full Text] [Related]
4. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
5. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
Weng MX; Wu CH; Yang XP
Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between CD44 expression or glycosylation and hepatocellular carcinoma metastasis].
Chen BL; Guo K; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):898-903. PubMed ID: 22525501
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Ezrin on differentiation and adhesion of hepatocellular carcinoma].
Guan XQ; Wang CJ; Li YY
Ai Zheng; 2002 Mar; 21(3):281-4. PubMed ID: 12451995
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in hepatocellular carcinoma treated with previous local treatment in patients undergoing living donor liver transplantation.
Kugiyama T; Hidaka M; Soyama A; Takatsuki M; Natsuda K; Kinoshita A; Carpenter I; Adachi T; Kitasato A; Kuroki T; Eguchi S
Transplant Proc; 2015 Apr; 47(3):700-2. PubMed ID: 25891714
[TBL] [Abstract][Full Text] [Related]
11. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
12. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
[TBL] [Abstract][Full Text] [Related]
14. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma.
Cho SB; Lee KH; Lee JH; Park SY; Lee WS; Park CH; Kim HS; Choi SK; Rew JS
Pathol Int; 2008 Oct; 58(10):635-42. PubMed ID: 18801083
[TBL] [Abstract][Full Text] [Related]
15. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
[TBL] [Abstract][Full Text] [Related]
17. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
19. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD44v6 and E-cadherin in prostate carcinoma and metastasis of prostate carcinoma].
Gu H; Shang P; Zhou C
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):32-4, 38. PubMed ID: 14979205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]